Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Las Vegas Sands Corp is a resorts & casinos business based in the US. Las Vegas Sands shares (LVS) are listed on the NYSE and all prices are listed in US Dollars. Las Vegas Sands employs 44,500 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$37.28|
|52-week range||$36.15 - $66.77|
|50-day moving average||$41.28|
|200-day moving average||$53.25|
|Wall St. target price||$63.92|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.76|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-2.33%|
|1 month (2021-08-24)||-12.73%|
|3 months (2021-06-24)||-28.20%|
|6 months (2021-03-24)||-36.98%|
|1 year (2020-09-24)||-18.80%|
|2 years (2019-09-24)||-33.03%|
|3 years (2018-09-24)||60.46|
|5 years (2016-09-23)||57.38|
Valuing Las Vegas Sands stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Las Vegas Sands's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Las Vegas Sands's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.513. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Las Vegas Sands's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Las Vegas Sands's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $91 million.
The EBITDA is a measure of a Las Vegas Sands's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.5 billion|
|Gross profit TTM||$1.8 billion|
|Return on assets TTM||-3.22%|
|Return on equity TTM||-47.38%|
|Market capitalisation||$29 billion|
TTM: trailing 12 months
There are currently 11.8 million Las Vegas Sands shares held short by investors – that's known as Las Vegas Sands's "short interest". This figure is 2.2% up from 11.6 million last month.
There are a few different ways that this level of interest in shorting Las Vegas Sands shares can be evaluated.
Las Vegas Sands's "short interest ratio" (SIR) is the quantity of Las Vegas Sands shares currently shorted divided by the average quantity of Las Vegas Sands shares traded daily (recently around 10.0 million). Las Vegas Sands's SIR currently stands at 1.18. In other words for every 100,000 Las Vegas Sands shares traded daily on the market, roughly 1180 shares are currently held short.
However Las Vegas Sands's short interest can also be evaluated against the total number of Las Vegas Sands shares, or, against the total number of tradable Las Vegas Sands shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Las Vegas Sands's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Las Vegas Sands shares in existence, roughly 20 shares are currently held short) or 0.0356% of the tradable shares (for every 100,000 tradable Las Vegas Sands shares, roughly 36 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Las Vegas Sands.
Find out more about how you can short Las Vegas Sands stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Las Vegas Sands.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 19.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Las Vegas Sands's overall score of 19.23 (as at 12/31/2018) is excellent – landing it in it in the 17th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Las Vegas Sands is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.94/100
Las Vegas Sands's environmental score of 1.94 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Las Vegas Sands is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 9.6/100
Las Vegas Sands's social score of 9.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Las Vegas Sands is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 6.19/100
Las Vegas Sands's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Las Vegas Sands is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Las Vegas Sands scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Las Vegas Sands has, for the most part, managed to keep its nose clean.
|Total ESG score||19.23|
|Total ESG percentile||17.25|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||2|
We're not expecting Las Vegas Sands to pay a dividend over the next 12 months.
Over the last 12 months, Las Vegas Sands's shares have ranged in value from as little as $36.15 up to $66.765. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Las Vegas Sands's is 1.4105. This would suggest that Las Vegas Sands's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Las Vegas Sands Corp. , together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the United States. It owns and operates The Venetian Macao Resort Hotel, the Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Hotel Macao, Cotai Strip, and the Sands Macao in Macao, the People's Republic of China; and Marina Bay Sands in Singapore. The company also owns and operates The Venetian Resort Hotel Casino on the Las Vegas Strip; and the Sands Expo and Convention Center in Las Vegas, Nevada. Its integrated resorts feature accommodations, gaming, entertainment and retail malls, convention and exhibition facilities, celebrity chef restaurants, and other amenities. Las Vegas Sands Corp. was founded in 1988 and is based in Las Vegas, Nevada.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.